BridgeBio Oncology Therapeutics Inc (BBOT)

11.96 +0.17%

BridgeBio Oncology Therapeutics Inc (BBOT) is currently trading at $11.96. This represents a gain of 0.17% from the previous session. With a market capitalization of $0.96B, BBOT is a key component of the Health Care sector. Investors looking to trade BBOT should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade BBOT commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, BridgeBio Oncology Therapeutics Inc (BBOT) shows a bullish trend. Analysts are watching the 12.13 level closely.

Fundamentals
Mkt Cap0.96B
P/E Ratio59.9200
Volume1,642
Others Watching (By Market Cap)
MLYS
Mineralys Thera $28.83
-3.77% DNTH
Dianthus Therap $52.45
-0.78% RARE
Ultragenyx Phar $22.56
-0.84% SLNO
Soleno Therapeu $40.13
+2.48% PAHC
Phibro Animal H $51.86
+0.77%
60-Day Technical Chart
Advanced Charting

Need more indicators for BBOT? Use the world's #1 platform.

Open BBOT on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $12
Metric BBOT
+0.17% 		IBRX
-4.92% 		OWL
+2.98% 		EOSE
-0.74%
Price $11.96 $10.98 $11.05 $11.39
Mkt Cap $0.96B $11.84B $16.92B $3.65B
- View → View → View →
Latest Headlines
We're Hopeful That BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Will Use Its Cash Wisely Yahoo Finance • Aug 17, 2025 BBOT Stock Price, News & Analysis Stock Titan • Aug 11, 2025 We Think BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Can Afford To Drive Business Growth simplywall.st • Aug 17, 2025 BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition GlobeNewswire • Aug 11, 2025 A Look At BridgeBio Oncology Therapeutics (BBOT) Valuation After Recent Share Price Momentum Yahoo Finance • Jan 25, 2026
● Gemini Agentic AI Analyst Insight for BBOT
Market Education
View All Articles →
External Research